Analyst Ratings for Rallybio
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Rallybio (NASDAQ:RLYB) stock. The analysts have an average price target of $17.0 versus the current price of Rallybio at $5.74, implying upside. This current average has decreased by 34.62% from the previous average price target of $26.00.
July 25, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a bullish outlook on Rallybio (NASDAQ:RLYB) with an average price target of $17.0, implying an upside from the current price of $5.74. However, this target has decreased by 34.62% from the previous average of $26.00.
The bullish outlook from analysts indicates a potential increase in Rallybio's stock price. However, the decrease in the average price target could suggest a less optimistic view than before, which might temper the potential upside.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100